HIV Exposure research study
Ref · 173A256558
MediTalk is recruiting up to 30 adults who may have a higher likelihood of HIV exposure to take part in an in-depth interview.
Thank-you
- US$150
About this study
MediTalk is recruiting up to 30 adults who may have a higher likelihood of HIV exposure to take part in an in-depth interview. We are currently working with a pharmaceutical company that is developing an oral HIV prevention medicine. The purpose of the interview is to gather feedback on a questionnaire that may be used in future clinical trials of this new medication. Eligible participants will be invited to take part in an individual interview online via Zoom or by telephone. The interview will include a few general questions about participants’ understanding and/or experience of HIV prevention medicine, followed by a review of the questionnaire and an opportunity to provide feedback. Eligible individuals will be asked to take part in an online interview over Zoom or the telephone. Each participant who qualifies and participates in an interview will receive a compensation for their time. During the individual interviews, participants will be asked a few general questions about their understanding and/or experience with HIV prevention medicine. They will then be asked to review and provide feedback on a questionnaire that may be used in future clinical trials. If you are interested in participating in an interview, please contact us.
Eligibility check
Self-reported eligibility , no diagnosis paperwork required.
Ready to take part?
Express interest in this study
Tap below to be taken back to the studies page where you can share your details with the research team.
Not on MediTalk yet? Create your free patient profile in 3 minutes and we'll match you to studies like this.